Tarveda Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States2-10 Employees

Tarveda Therapeutics is a clinical-stage biotechnology company focused on developing precision oncology medicines called Pentarin miniature drug conjugates for solid tumors. It is based in Watertown, Massachusetts, at 134 Coolidge Avenue, and maintains a small team of 2-10 employees. The Pentarin platform is designed to penetrate solid tumors, selectively bind to tumor targets, and release anti-cancer payloads within tumor cells. The lead program, PEN-866, is a HSP90-binding miniature drug conjugate linked to the SN-38 payload and has commenced a Phase 2a trial across various solid tumors. Tarveda is developing additional miniature drug conjugates on the same HSP90 platform to target other payloads such as kinase inhibitors and radioisotopes. In 2026, there was leadership change with the departure of the Chief Scientific Officer and President of R&D.

Sign up for free to view info

Company overview Employee directory